{"nctId":"NCT00402103","briefTitle":"An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure","startDateStruct":{"date":"2006-11"},"conditions":["Hypertension"],"count":556,"armGroups":[{"label":"Aliskiren/Amlodipine","type":"EXPERIMENTAL","interventionNames":["Drug: Aliskiren","Drug: Amlodipine"]},{"label":"Aliskiren/Amlodipine/HCTZ","type":"EXPERIMENTAL","interventionNames":["Drug: Aliskiren","Drug: Amlodipine","Drug: Hydrochlorothiazide"]}],"interventions":[{"name":"Aliskiren","otherNames":[]},{"name":"Amlodipine","otherNames":[]},{"name":"Hydrochlorothiazide","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Outpatients 18 years of age or older\n* Male or female patients are eligible\n* For newly diagnosed/untreated patients with essential hypertension defined as msDBP ≥ 90 and \\< 110 mmHg at Visit 1 and Visit 4\n* For previously treated patients with essential hypertension defined as msDBP ≥ 90 and \\< 110 mmHg after 2 to 4 weeks of washout (Visit 4)\n\nExclusion Criteria:\n\n* Severe hypertension\n* History or evidence of a secondary form of hypertension\n* History of Hypertensive encephalopathy or cerebrovascular accident.\n\nOther protocol-defined inclusion/exclusion criteria may apply","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Overall Percentage of Patients With Adverse Events","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.6","spread":null},{"groupId":"OG001","value":"71.2","spread":null},{"groupId":"OG002","value":"57.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Mean Sitting Diastolic Blood Pressure (msDBP)From Baseline to the Indicated Time Points","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.7","spread":"6.94"},{"groupId":"OG001","value":"-5.9","spread":"6.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.0","spread":"6.88"},{"groupId":"OG001","value":"-11.9","spread":"5.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.7","spread":"6.96"},{"groupId":"OG001","value":"-11.5","spread":"7.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.3","spread":"6.69"},{"groupId":"OG001","value":"-9.3","spread":"7.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.1","spread":"6.84"},{"groupId":"OG001","value":"-13.1","spread":"7.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.7","spread":"7.15"},{"groupId":"OG001","value":"-14.7","spread":"8.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.0","spread":"7.26"},{"groupId":"OG001","value":"-15.4","spread":"6.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.3","spread":"7.13"},{"groupId":"OG001","value":"-15.3","spread":"6.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.7","spread":"7.61"},{"groupId":"OG001","value":"-14.2","spread":"7.90"}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients Achieving a Blood Pressure Control Target of <140/90 mmHg","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.3","spread":"88.0"},{"groupId":"OG001","value":"8.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88.0","spread":null},{"groupId":"OG001","value":"16.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"88.2","spread":null},{"groupId":"OG001","value":"56.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82.0","spread":null},{"groupId":"OG001","value":"62.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77.3","spread":null},{"groupId":"OG001","value":"58.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients Achieving a Response in Mean Sitting Diastolic Blood Pressure (msDBP)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"61.2","spread":null},{"groupId":"OG001","value":"38.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96.8","spread":null},{"groupId":"OG001","value":"61.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"95.9","spread":null},{"groupId":"OG001","value":"85.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"93.2","spread":null},{"groupId":"OG001","value":"89.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90.6","spread":null},{"groupId":"OG001","value":"84.9","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":556},"commonTop":["Oedema peripheral","Upper respiratory tract infection","Muscle spasms"]}}}